CurrentEndo coverage · page 42 of 55

Diabetes, Obesity and Metabolism

Briefs 1,641–1,680 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

Diabetes Obes Metab8 May 2024
Obesity‐induced tissue alterations resist weight loss: A mechanistic review
Mechanistic studyObesity
Diabetes Obes Metab7 May 2024
A randomized, double‐blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes ( AWARD‐JPN )
Randomized controlled trialT2D & other
Diabetes Obes Metab6 May 2024
Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors and dipeptidyl peptidase‐4 inhibitors in improvement of fatty liver index in patients with type 2 diabetes mellitus and metabolic dysfunction‐associated steatotic liver disease: A retrospective nationwide claims database study in Japan
Cohort studyT2D & other
Diabetes Obes Metab3 May 2024
Pioglitazone reduces serum ketone bodies in sodium‐glucose cotransporter ‐2 inhibitor‐treated non‐obese type 2 diabetes: A single‐centre, randomized, crossover trial
Randomized controlled trialT2D & other
Diabetes Obes Metab3 May 2024
Earlier detection of gestational diabetes impacts on medication requirements, neonatal and maternal outcomes
Cohort studyDiabetes in pregnancy
Diabetes Obes Metab2 May 2024
Prescription medication use among patients with type 2 diabetes in the United States: 1999–2020
Cross-sectional studyT2D & other
Diabetes Obes Metab2 May 2024
Investigating the causal association of generalized and abdominal obesity with microvascular complications in patients with type 2 diabetes: A community‐based prospective study
Cohort studyComplications
Diabetes Obes Metab2 May 2024
Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the STEP 1–4 trials
Secondary analysisObesity
Diabetes Obes Metab2 May 2024
Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population‐based cohort study
Cohort studyT2D & other
Diabetes Obes Metab2 May 2024
Gastric emptying in newly diagnosed, treatment‐naïve Han Chinese with type 2 diabetes and the impact of 4‐week insulin pump therapy
Cohort studyTechnology
Diabetes Obes Metab2 May 2024
Gastric emptying is slower in women than men with type 2 diabetes and impacts on postprandial glycaemia
Cross-sectional studyT2D & other
Diabetes Obes Metab30 Apr 2024
Adiposity indicators exhibit depot‐ and sex‐specific associations with multimorbidity onset: A cohort study of the UK Biobank
Cohort studyObesity
Diabetes Obes Metab29 Apr 2024
Association of lifestyle with reduced stroke risk in 41 314 individuals with diabetes: Two prospective cohort studies in China
Cohort studyComplications
Diabetes Obes Metab29 Apr 2024
Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3‐year prospective cohort study
Cohort studyLipids & liver
Diabetes Obes Metab28 Apr 2024
Association of gestational diabetes with long‐term risk of premature mortality, and cardiovascular outcomes and risk factors: A retrospective cohort analysis in the UK Biobank
Cohort studyDiabetes in pregnancy
Diabetes Obes Metab28 Apr 2024
Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial
Research articleTechnology
Diabetes Obes Metab28 Apr 2024
Once‐weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme
Trial designT2D & other
Diabetes Obes Metab28 Apr 2024
Real‐world effectiveness of sodium‐glucose cotransporter‐2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria
Cohort studyT2D & other
Diabetes Obes Metab23 Apr 2024
Cross‐sectional, case‐control and longitudinal associations between exposure to glucagon‐like peptide‐1 receptor agonists and the dispensing of antidepressants
Case-control studyT2D & other
Diabetes Obes Metab22 Apr 2024
Biotransformation and disposition characteristics of HSK7653 , a novel long‐acting dipeptidyl peptidase‐4 inhibitor for the treatment of type 2 diabetes
Research articleT2D & other
Diabetes Obes Metab22 Apr 2024
C‐peptide index at 2 h post‐meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes
Cohort studyT2D & other
Diabetes Obes Metab21 Apr 2024
Cardiorenal outcomes and mortality after sodium‐glucose cotransporter‐2 inhibitor initiation in type 2 diabetes patients with percutaneous coronary intervention history
Cohort studyT2D & other
Diabetes Obes Metab18 Apr 2024
A meta‐analysis of the association between RBP4 rs3758539 genotype and metabolic syndrome factors
Meta-analysisLipids & liver
Diabetes Obes Metab18 Apr 2024
Identification of diagnostic biomarkers used in the diagnosis of cardiovascular diseases and diabetes mellitus: A systematic review of quantitative studies
Meta-analysisT2D & other
Diabetes Obes Metab18 Apr 2024
Real‐world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international, multicentre, 12‐month, prospective observational study
Cohort studyT2D & other
Diabetes Obes Metab15 Apr 2024
Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non‐interventional study in Kenya
Diagnostic or prognostic studyComplications
Diabetes Obes Metab15 Apr 2024
Smoking timing, genetic susceptibility and the risk of incident type 2 diabetes: A cohort study from the UK Biobank
Cohort studyT2D & other
Diabetes Obes Metab15 Apr 2024
The Obese Taste Bud study: Objectives and study design
Cohort studyObesity
Diabetes Obes Metab15 Apr 2024
Combination of retagliptin and henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, active‐controlled, phase 3 trial
Randomized controlled trialT2D & other
Diabetes Obes Metab15 Apr 2024
Time trends and regional variation in utilization of antidiabetic medicines in China, 2015–2022
Cross-sectional studyT2D & other
Diabetes Obes Metab15 Apr 2024
Association of single‐point insulin sensitivity estimator index (SPISE) with future cardiovascular outcomes in patients with type 2 diabetes
Cohort studyT2D & other
Diabetes Obes Metab15 Apr 2024
The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium‐glucose cotransporter ‐2 inhibitor, in type 2 diabetes
Research articleT2D & other
Diabetes Obes Metab15 Apr 2024
Geographic variation in sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia
Cross-sectional studyT2D & other
Diabetes Obes Metab11 Apr 2024
Artificial intelligence‐enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes
Diagnostic or prognostic studyComplications
Diabetes Obes Metab11 Apr 2024
Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta‐analysis of randomized controlled trials
Meta-analysisT1D
Diabetes Obes Metab11 Apr 2024
Retagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
Randomized controlled trialT2D & other
Diabetes Obes Metab11 Apr 2024
The effect of sodium‐glucose cotransporter‐2 inhibitors on inflammatory biomarkers: A meta‐analysis of randomized controlled trials
Meta-analysisT2D & other
Diabetes Obes Metab8 Apr 2024
Effects of high‐dose versus standard‐dose quadrivalent influenza vaccine among patients with diabetes: A post‐hoc analysis of the DANFLU ‐1 trial
Secondary analysisT2D & other
Diabetes Obes Metab8 Apr 2024
Prediction of new‐onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS
Diagnostic or prognostic studyT2D & other
Diabetes Obes Metab8 Apr 2024
Sleep duration and association with cardiometabolic health in adolescents and adults with type 1 diabetes: Results from the BCQR‐T1D study
Secondary analysisT1D

All 2,200 Briefs in ExploreShowing Briefs 1,641–1,680 of 2,200, newest first